Axcella Reports First Quarter Financial Results and Provides Business Update
Long COVID Phase 2b/3 clinical trial may proceed under U.S. Investigational New Drug applicationMHRA guidance aligns on key measurements for a Long COVID registration trial, including primary endpoint and trial design elementsLancet eClinical Medicine published findings from the Phase 2a clinical trial of AXA1125 in...
Source: pharmiweb.com
